online casino bonus new
Sep. 14--MUMBAI, India -- India's Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales of $700 million in the US alone. A US federal appeals court has ruled that the patent for Altace, chemically known as ramipril, was invalid on grounds of being obvious. Thus, the court overturned a lower court ruling that Lupin had infringed the patent by seeking approval to market a generic version of the drug. Related Results King and Dura give old drugs new life in the marketplace Rica Hotels ASA to expand Rica Hotel Alta King Pharmaceuticals to license Skyepharma's delivery technology. inflight gambling system free black rhino slots universal slot manual rated online casino best gaming experience
